UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.051

Sortiert nach

What is needed for the roll-out of psychedelic treatments?

Current opinion in psychiatry, 2024-07, Vol.37 (4), p.277

2024

Link zum Volltext

Verfügbarkeit prüfen

Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review

Journal of affective disorders, 2024-06, Vol.355, p.342-354

2024

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of therapeutic change after psychedelic treatment in OCD

Psychiatry research, 2024-06, Vol.336, p.115907, Article 115907

2024

Link zum Volltext

Verfügbarkeit prüfen

Psychedelics and Evidence-based Psychotherapy: A Systematic Review with Recommendations for Advancing Psychedelic Therapy Research

The Psychiatric clinics of North America, 2024-06, Vol.47 (2), p.367-398

2024

Link zum Volltext

Verfügbarkeit prüfen

Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression

Psychological medicine, 2024-06, Vol.54 (8), p.1717-1724

2024

Link zum Volltext

Verfügbarkeit prüfen

Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases

Pharmacology & therapeutics (Oxford), 2024-06, Vol.258, p.108641, Article 108641

2024

Link zum Volltext

Verfügbarkeit prüfen

The Long Road Toward Equitable MDMA Treatment in the United States

The journal of clinical psychiatry, 2024-05, Vol.85 (2)

2024

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Psilocybin's Adverse Effects Mostly Resolved Within 2 Days

JAMA : the journal of the American Medical Association, 2024-05, Vol.331 (20), p.1699

Harris, Emily

2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial

Trials, 2024-05, Vol.25 (1), p.336-336, Article 336

2024

Link zum Volltext

Verfügbarkeit prüfen

Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial

Journal of the neurological sciences, 2024-05, Vol.460, p.122993-122993, Article 122993

2024

Link zum Volltext

Verfügbarkeit prüfen

PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION

Neurosciences (Riyadh, Saudi Arabia), 2024-05, Vol.29 (2), p.151-152

2024

Link zum Volltext

Verfügbarkeit prüfen

MDMA-assisted therapy for PTSD

Laeknabladid, 2024-05, Vol.110 (5), p.254

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis

Psychiatry research, 2024-05, Vol.335, p.115886, Article 115886

2024

Link zum Volltext

Verfügbarkeit prüfen

National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022

Drug and alcohol dependence, 2024-05, Vol.258, p.111086-111086, Article 111086

2024

Link zum Volltext

Verfügbarkeit prüfen

Psilocybin for depression

BMJ (Online), 2024-05, Vol.385, p.q798

2024

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies

Journal of Neural Transmission, 2024-05, Vol.131 (5), p.525-561

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis

BMJ (Online), 2024-05, Vol.385, p.e078084

2024

Link zum Volltext

Verfügbarkeit prüfen

Integrating Psychedelics into Digital Health: A New Horizon in Mental Wellness

Cyberpsychology, behavior and social networking, 2024-05, Vol.27 (5), p.297

Wiederhold, Brenda K

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical management of treatment-resistant depression

Nervenarzt, 2024-05, Vol.95 (5), p.416-422

2024

Link zum Volltext

Verfügbarkeit prüfen

Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks

Journal of Psychopharmacology, 2024-05, Vol.38 (5), p.407-416

2024

Link zum Volltext

Verfügbarkeit prüfen

The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin

BMC psychiatry, 2024-04, Vol.24 (1), p.319-319, Article 319

2024

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers

Progress in neuro-psychopharmacology & biological psychiatry, 2024-04, Vol.131, p.110951-110951, Article 110951

2024

Link zum Volltext

Verfügbarkeit prüfen

"Everything is kind of the same except my mind is with me": exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction

Harm reduction journal, 2024-04, Vol.21 (1), p.83-83, Article 83

2024

Link zum Volltext

Verfügbarkeit prüfen

Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019

Drug and alcohol dependence, 2024-04, Vol.257, p.111113-111113, Article 111113

2024

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with the use of psychedelics, ketamine and MDMA among sexual and gender minority youths in Canada: a machine learning analysis

Journal of epidemiology and community health (1979), 2024-04, Vol.78 (4), p.248

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.051

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(938)
Mit Volltextzugriff
(762)

Publikationsform

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

What is needed for the roll-out of psychedelic treatments?

Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review

Mechanisms of therapeutic change after psychedelic treatment in OCD

Psychedelics and Evidence-based Psychotherapy: A Systematic Review with Recommendations for Advancing Psychedelic Therapy Research

Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression

Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases

The Long Road Toward Equitable MDMA Treatment in the United States

Therapeutic Psilocybin's Adverse Effects Mostly Resolved Within 2 Days

Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial

Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial

PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION

MDMA-assisted therapy for PTSD

Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis

National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022

Psilocybin for depression

Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies

Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis

Integrating Psychedelics into Digital Health: A New Horizon in Mental Wellness

Clinical management of treatment-resistant depression

Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks

The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin

Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers

"Everything is kind of the same except my mind is with me": exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction

Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019

Factors associated with the use of psychedelics, ketamine and MDMA among sexual and gender minority youths in Canada: a machine learning analysis

Suchergebnisse filtern